tau ELISA Kit

Catalog No. ABIN5067912

Human tau ELISA Kit Colorimetric assay for quantification of Human tau.

Quick Overview for tau ELISA Kit (ABIN5067912)

Target: tau (tau Protein)

Reactivity: Human

Detection Method: Colorimetric

Application: ELISA

Sample Type: Biological Buffers, Cell Culture Supernatant, Cerebrospinal Fluid

Product Details tau ELISA Kit

Purpose: Tau, Total, Human (Tau Protein, Microtubule-associated Protein, MAP) ELISA Kit is used for the quantitative determination of human total Tau protein.

Analytical Method: Quantitative

Sensitivity: > 12 pg/mL

Characteristics: Tau, Total, Human (Tau Protein, Microtubule-associated Protein, MAP) ELISA Kit

Components:

• Microtiter Plate 1x96 wells Coated with human Tau antibody
• Standard 2x1 vial
• Standard Diluent Buffer. 1x25ml
• Detection Antibody 1x11ml
• Pab (HRP), 100X 1x125ul
• HRP Diluent 1x25ml
• Wash Buffer, 25X 1x100ml
• TMB 1x25ml
• Stop Solution 1x25ml

Application Details

Restrictions: For Research Use only

Handling

Storage: 4 °C

Storage Comment: 4°C

Target Details for tau

Target: tau (tau Protein)

Alternative Name: Tau

Background: Tau is a microtubule associated protein found predominantly in neuronal axons of vertebrate brain. Tau protein is highly soluble and normally attached to axonal microtubules. Tau stabilizes the microtubules and makes them rigid. Tau interacts with actin in the cytoskeleton and neuronal outgrowth, anchors enzymes such as protein kinases and phosphatases, and regulates intracellular vesicle transport. Tau phosphorylation regulates both normal and pathological functions of this protein. Tau, in its hyperphosphorylated form, is the major component of paired helical filaments (PHFs), the building block of neurofibrillary lesions in Alzheimer's disease (AD). Hyperphosphorylation impairs the microtubule binding function of tau, resulting in the destabilization of microtubules in AD brains, ultimately leading to neuronal degeneration. Deposition of filamentous tau is implicated in other neurodegenerative diseases including cortical basal degeneration (CBD), progressive supranuclear palsy (PSP), Pick's disease and certain forms of Parkinson's disease.